Evaluation of a Leukocyte Stabilization Reagent for Use in the Cytomegalovirus pp65 Antigenemia Assay

AUTOR(ES)

Bush, Charlene E.

FONTE

American Society for Microbiology

RESUMO

New erythrocyte lysis and leukocyte stabilization reagents (Streck Laboratories, Inc.) were tested in the cytomegalovirus pp65 antigenemia assay, to determine if whole-blood processing time could be delayed to 24 h postdraw. The combination of these reagents gave results comparable to those for patient samples processed immediately after blood draw.

Documentos Relacionados

• Leukocyte Stabilization Reagent for Use in the Cytomegalovirus pp65 Antigenemia Assay
• Leukocyte Concentration in the Performance of the pp65 Antigenemia Assay
• 2-Hour Cytomegalovirus pp65 Antigenemia Assay for Rapid Quantitation of Cytomegalovirus in Blood Samples
• Pp65 antigenemia for cytomegalovirus infection diagnosis in AIDS patients
• Interest of quantitative pp65 cytomegalovirus antigenemia assay for human immunodeficiency virus-positive patients.